The PALM MicroBeam laser microdissection system provides for non-contact (contamination-free) isolation of homogeneous specimens from tissue or the acquisition of living cells, which facilitates the molecular analysis of DNA, RNA and proteins.
A flexible, high-throughput DNA methylation profiling technology has been introduced that is capable of surveying up to 1,536 methylation sites across 96 samples simultaneously. Illumina Inc.
A diverse selection of cyclin-dependent kinase (CDK) inhibitors is available from Axxora. The family of inhibitors consists of over 35 reagents, including selective inhibitors for CDK-1, CDK-2, CDK-4, CDK-5, and GSK-3B as well as other enzymes.
Listing of awarded and available funding
Source: The University of Texas Southwestern Medical Center, Dallas
Source: Dana-Farber Cancer Institute, Boston
Listing of licensing and service agreements
Source: Cedars-Sinai Medical Center, Los Angeles
Source: National Cancer Institute, Bethesda, Md.
Source: Beth Israel Deaconess Medical Center, Boston
Source: Vanderbilt University Medical Center, Nashville
Source: State University of New York at Buffalo
Listing of drug developments and approvals
Source: University of North Carolina, Chapel Hill
Source: Mayo Clinic, Rochester, Minn.
Source: St. Jude Children's Research Hospital, Memphis, Tenn.
The rate of cancer incidence continues to remain stable while the death rate from cancer continues to decline, states the 2005 Cancer Trends Progress Report Update, published by the National Cancer Institute (NCI).
Source: Lustgarten Foundation for Pancreatic Cancer Research, Bethpage, N.Y.
The benefits of automating biological assays include the elimination of problems introduced through human error, increased throughput and consistency, and decreased costs.
MHC Class II Ultimers facilitate evaluation and characterization of CD4+ single antigen-specific T cells, enabling evaluation of the T cell immune response in a wide range of disease areas including, autoimmune disease, cancer and infectious diseases.
Listing of collaborations, acquisitions, and mergers
Source: University of California, Irvine
Source: Johns Hopkins Kimmel Cancer Center, Baltimore
Source: Methodist Hospital, Houston
Source: Thomas Jefferson University, Philadelphia